Skip to main content
Log in

Fosmidomycin for the treatment of malaria

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract.

In malaria parasites, isoprenoids are synthesised by the mevalonate independent 1-deoxy-D-xylulose 5-phosphate (DOXP) pathway. Fosmidomycin, a natural antibiotic originally developed for the treatment of bacterial infections, represents an inhibitor of DOXP reductoisomerase, an essential enzyme of this pathway. In recent clinical studies it was shown that fosmidomycin is effective in curing uncomplicated Plasmodium falciparum malaria in humans. The treatment was well tolerated and resulted in a fast parasite and fever clearance. However, the high rate of recrudescence precludes the use of fosmidomycin as a monotherapy. In drug combination studies, synergy of fosmidomycin with clindamycin was observed. Clinical studies with a fosmidomycin-clindamycin combination are currently ongoing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  • Altincicek B, Kollas AK, Sanderbrand S, Wiesner J, Hintz M, Beck E, Jomaa H (2001a) GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. J Bacteriol 183:2411–2416

    Google Scholar 

  • Altincicek B, Kollas A, Eberl M, Wiesner J, Sanderbrand S, Hintz M, Beck E, Jomaa H (2001b) LytB, a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. FEBS Lett 499:37–40

    Google Scholar 

  • Beytia ED, Porter JW (1976) Biochemistry of polyisoprenoid biosynthesis. Annu Rev Biochem 45:113–142

    Google Scholar 

  • Chakrabarti D, Azam T, DelVecchio C, Qiu L, Park YI, Allen CM (1998) Protein prenyl transferase activities of Plasmodium falciparum. Mol Biochem Parasitol 94:175–184

    Google Scholar 

  • Couto AS, Kimura EA, Peres VJ, Uhrig ML, Katzin AM (1999) Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem J 341:629–637

    Google Scholar 

  • De Macedo CS, Uhrig ML, Kimura EA, Katzin AM (2002) Characterization of the isoprenoid chain of coenzyme Q in Plasmodium falciparum. FEMS Microbiol Lett 207:13–20

    Google Scholar 

  • Disch A, Schwender J, Muller C, Lichtenthaler HK, Rohmer M (1998) Distribution of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem J 333:381–388

    Google Scholar 

  • Dumas R, Biou V, Halgand F, Douce R, Duggleby RG (2001) Enzymology, structure, and dynamics of acetohydroxy acid isomeroreductase. Acc Chem Res 34:399–408

    Google Scholar 

  • Fichera ME, Roos DS (1997) A plastid organelle as a drug target in apicomplexan parasites. Nature 390:407–409

    Google Scholar 

  • Grellier P, Valentin A, Millerioux V, Schrevel J, Rigomier D (1994) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother 38:1144–12148

  • Hecht S, Eisenreich W, Adam P, Amslinger S, Kis K, Bacher A, Arigoni D, Rohdich F (2001) Studies on the nonmevalonate pathway to terpenes: the role of the GcpE (IspG) protein. Proc Natl Acad Sci U S A 98:14837–14842

    Google Scholar 

  • Herz S, Wungsintaweekul J, Schuhr CA, Hecht S, Luttgen H, Sagner S, Fellermeier M, Eisenreich W, Zenk MH, Bacher A, Rohdich F (2000) Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate to 2C-methyl-D-erythritol 2,4-cyclodiphosphate. Proc Natl Acad Sci U S A 97:2486–2490

    Google Scholar 

  • Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Turbachova I, Eberl M, Zeidler J, Lichtenthaler HK, Soldati D, Beck E (1999) Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285:1573–1576

    Google Scholar 

  • Kamiya T, Hashimoto M, Hemmi K, Takeno H (1980) Hydroxyaminohydrocarbon-phosphonic acids. Fujisawa Pharmaceutical Company, US-patent no. 4206156

  • Köhler S, Delwiche CF, Denny PW, Tilney LG, Webster P, Wilson RJ, Palmer JD, Roos DS (1997) A plastid of probable green algal origin in apicomplexan parasites. Science 275:1485–1489

    Google Scholar 

  • Koppisch AT, Fox DT, Blagg BS, Poulter CD (2002) E. coli MEP synthase: steady-state kinetic analysis and substrate binding. Biochemistry 41:236–243

    Google Scholar 

  • Kremsner PG (1990) Clindamycin in malaria treatment. J Antimicrob Chemother 25:9–14

    Google Scholar 

  • Kuemmerle HP, Murakawa T, Soneoka K, Konishi T (1985a) Fosmidomycin: a new phosphonic acid antibiotic. Part I: phase I tolerance studies. Int J Clin Pharmacol Ther Toxicol 23:515–20

    Google Scholar 

  • Kuemmerle HP, Murakawa T, Sakamoto H, Sato N, Konishi T, De Santis F (1985b) Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies. Int J Clin Pharmacol Ther Toxicol 23:521–528

    Google Scholar 

  • Kuzuyama T, Shizimu T, Takahashi S, Seto H (1998) Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway of isoprenoidbiosynthesis. Tetrahedron Lett 39:7913–7916

    Google Scholar 

  • Lell B, Ruangweerayut R, Wiesner J, Missinou MA, Schindler A, Baranek T, Hintz M, Hutchinson D, Jomaa H, Kremsner PG (2002) Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob Agents Chemother (in press)

  • Mbaya B, Rigomier D, Edorh GG, Karst F, Schrevel J (1990) Isoprenoid metabolism in Plasmodium falciparum during the intraerythrocytic phase of malaria. Biochem Biophys Res Commun 173:849–854

    Google Scholar 

  • Missinou MA, Borrmann S, Schindler A, Issifou S Adegnika A, Matsiegui PB, Binder R, Lell B, Kremsner PG, Wiesner J, Baranek T, Jomaa H (2002) Fosmidomycin for malaria. Lancet (in press)

  • Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H (1980) Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J Antibiot (Tokyo) 33:24–28.

    Google Scholar 

  • Parola P, Ranque S, Badiaga S, Niang M, Blin O, Charbit JJ, Delmont J, Brouqui P (2001) Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Antimicrob Agents Chemother 45:932–935

    Google Scholar 

  • Reichenberg A, Wiesner J, Weidemeyer C, Dreiseidler E, Sanderbrand S, Altincicek B, Beck E, Schlitzer M, Jomaa H (2001) Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Bioorg Med Chem Lett 11:833–835

    Google Scholar 

  • Reuter K, Sanderbrand S, Jomaa H, Wiesner J, Steinbrecher I, Beck E, Hintz M, Klebe G, Stubbs MT (2002) Crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, a crucial enzyme in the non-mevalonate pathway of isoprenoid biosynthesis. J Biol Chem 277:5378–5384

    Google Scholar 

  • Rohdich F, Eisenreich W, Wungsintaweekul J, Hecht S, Schuhr CA, Bacher A (2001) Biosynthesis of terpenoids. 2C-Methyl-D-erythritol 2,4-cyclodiphosphate synthase (IspF) from Plasmodium falciparum. Eur J Biochem 268:3190–3197

    Google Scholar 

  • Rohdich F, Hecht S, Gartner K, Adam P, Krieger C, Amslinger S, Arigoni D, Bacher A, Eisenreich W (2002) Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein. Proc Natl Acad Sci U S A 99:1158–1163

    Google Scholar 

  • Rohmer M (1999) The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat Prod Rep 16:565–574

    Google Scholar 

  • Rohmer M, Knani M, Simonin P, Sutter B, Sahm H (1993) Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem J 295:517–524

    Google Scholar 

  • Seto H, Wtanabe H, Furihata K (1996) Simultaneous operation of the mevalonate and non-mevalonate pathways in the biosynthesis of isopentenyl diphosphate in Streptomyces aeriouvifer. Tetrahedron Lett 37:7979–7982

    Google Scholar 

  • Skelton FS, Lunan KD, Folkers K, Schnell JV, Siddiqui WA, Geiman QM (1969) Biosynthesis of ubiquinones by malarial parasites. I. Isolation of [14C]ubiquinones from cultures of rhesus monkey blood infected with Plasmodium knowlesi. Biochemistry 8:1284–1287

    Google Scholar 

  • Tsuchiya T, Ishibashi K, Terakawa M, Nishiyama M, Itoh N, Noguchi H (1982) Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs. Eur J Drug Metab Pharmacokinet 7:59–64

    Google Scholar 

  • Vial HJ, Philippot JR, Wallach DF (1984) A reevaluation of the status of cholesterol in erythrocytes infected by Plasmodium knowlesi and P. falciparum. Mol Biochem Parasitol 13:53–65

  • Wiesner J, Hintz M, Altincicek B, Sanderbrand S, Weidemeyer C, Beck E, Jomaa H (2000) Plasmodium falciparum: detection of the deoxyxylulose 5-phosphate reductoisomerase activity. Exp Parasitol 96:182–186

    Google Scholar 

  • Wiesner J, Henschker D, Hutchinson DB, Beck E, Jomaa H (2002) In vitro and in vivo synergy of fosmidoymcin, a new antimalerial drug, with clindamycin. Antimicrob Agents Chemother 46:2889–2894

    Google Scholar 

  • Wunderlich F, Fiebig S, Vial H, Kleinig H (1991) Distinct lipid compositions of parasite and host cell plasma membranes from Plasmodium chabaudi-infected erythrocytes. Mol Biochem Parasitol 44:271–277

    Google Scholar 

  • Yajima S, Nonaka T, Kuzuyama T, Seto H, Ohsawa K (2002) Crystal structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase complexed with cofactors: implications of a flexible loop movement upon substrate binding. J Biochem (Tokyo) 131:313–317

    Google Scholar 

  • Zeidler J, Schwender J, Müller C, Wiesner J, Weidemeyer C, Beck E, Jomaa H, Lichtenthaler HK (1998) Inhibition of the non-mevalonate 1-deoxy-D-xylulose-5-phosphate pathway of plant isoprenoid biosynthesis by fosmidomycin. Z Naturforsch C 53:980–986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jochen Wiesner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiesner, J., Borrmann, S. & Jomaa, H. Fosmidomycin for the treatment of malaria. Parasitol Res 90 (Suppl 2), S71–S76 (2003). https://doi.org/10.1007/s00436-002-0770-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-002-0770-9

Keywords

Navigation